228 related articles for article (PubMed ID: 20025747)
1. Pre-radiotherapy plasma carotenoids and markers of oxidative stress are associated with survival in head and neck squamous cell carcinoma patients: a prospective study.
Sakhi AK; Russnes KM; Thoresen M; Bastani NE; Karlsen A; Smeland S; Blomhoff R
BMC Cancer; 2009 Dec; 9():458. PubMed ID: 20025747
[TBL] [Abstract][Full Text] [Related]
2. Postradiotherapy plasma lutein, alpha-carotene, and beta-carotene are positively associated with survival in patients with head and neck squamous cell carcinoma.
Sakhi AK; Bøhn SK; Smeland S; Thoresen M; Smedshaug GB; Tausjø J; Svilaas A; Karlsen A; Russnes KM; Svilaas T; Blomhoff R
Nutr Cancer; 2010; 62(3):322-8. PubMed ID: 20358469
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of serum levels of oxidized and reduced glutathione and total antioxidant capacity in patients with head and neck squamous cell carcinoma.
Pakfetrat A; Dalirsani Z; Hashemy SI; Ghazi A; Mostaan LV; Anvari K; Pour AM
J Cancer Res Ther; 2018; 14(2):428-431. PubMed ID: 29516932
[TBL] [Abstract][Full Text] [Related]
4. Nitric oxide and antioxidant status in head and neck carcinoma before and after radiotherapy.
Dahiya K; Dhankhar R; Madaan H; Singh V; Arora K
Ann Clin Lab Sci; 2012; 42(1):94-7. PubMed ID: 22371916
[TBL] [Abstract][Full Text] [Related]
5. Post-radiotherapy plasma total glutathione is associated to outcome in patients with head and neck squamous cell carcinoma.
Bøhn SK; Smeland S; Sakhi AK; Thoresen M; Russnes KM; Tausjø J; Svilaas A; Svilaas T; Blomhoff R
Cancer Lett; 2006 Jul; 238(2):240-7. PubMed ID: 16157445
[TBL] [Abstract][Full Text] [Related]
6. Pre-therapeutic fibrinogen levels are of prognostic significance in locally advanced head and neck cancer.
Selzer E; Grah A; Heiduschka G; Kornek G; Thurnher D
Wien Klin Wochenschr; 2016 May; 128(9-10):320-8. PubMed ID: 26919854
[TBL] [Abstract][Full Text] [Related]
7. Serum prognostic biomarkers in head and neck cancer patients.
Lin HS; Siddiq F; Talwar HS; Chen W; Voichita C; Draghici S; Jeyapalan G; Chatterjee M; Fribley A; Yoo GH; Sethi S; Kim H; Sukari A; Folbe AJ; Tainsky MA
Laryngoscope; 2014 Aug; 124(8):1819-26. PubMed ID: 24347532
[TBL] [Abstract][Full Text] [Related]
8. An investigation of oxidative stress and coenzyme Q10 levels in patients with head and neck squamous cell carcinomas.
Aksoy A; Kurnaz SÇ
Eur Arch Otorhinolaryngol; 2019 Apr; 276(4):1197-1204. PubMed ID: 30729295
[TBL] [Abstract][Full Text] [Related]
9. Squamous cell carcinoma antigen as a prognostic marker and its correlation with clinicopathological features in head and neck squamous cell carcinoma: Systematic review and meta-analysis.
Travassos DC; Fernandes D; Massucato EMS; Navarro CM; Bufalino A
J Oral Pathol Med; 2018 Jan; 47(1):3-10. PubMed ID: 28600896
[TBL] [Abstract][Full Text] [Related]
10. Prognostic relevance of insulin resistance on disease-free survival in head and neck squamous cell carcinomas: Preliminary results.
Avilés-Jurado FX; Flores JC; Gumà J; Ceperuelo-Mallafré V; Casanova-Marqués R; Gómez D; Vendrell JJ; León X; Vilaseca I; Terra X
Head Neck; 2017 Dec; 39(12):2501-2511. PubMed ID: 28963801
[TBL] [Abstract][Full Text] [Related]
11. Trace metals and total antioxidant potential in head and neck cancer patients.
Akinmoladun VI; Owotade FJ; Olusanya AA
Ann Afr Med; 2013; 12(2):131-4. PubMed ID: 23713022
[TBL] [Abstract][Full Text] [Related]
12. [Neutrophil to lymphocyte ratio in peripheral blood: a novel independent prognostic factor in patients with head and neck squamous cell carcinoma].
Wu F; Wu LL; Zhu LX
Zhonghua Zhong Liu Za Zhi; 2017 Jan; 39(1):29-32. PubMed ID: 28104030
[No Abstract] [Full Text] [Related]
13. Survival Patterns in Elderly Head and Neck Squamous Cell Carcinoma Patients Treated With Definitive Radiation Therapy.
Sommers LW; Steenbakkers RJHM; Bijl HP; Vemer-van den Hoek JGM; Roodenburg JLN; Oosting SF; Halmos GB; de Rooij SE; Langendijk JA
Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):793-801. PubMed ID: 28476434
[TBL] [Abstract][Full Text] [Related]
14. Pretreatment albumin level predicts survival in head and neck squamous cell carcinoma.
Lim WS; Roh JL; Kim SB; Choi SH; Nam SY; Kim SY
Laryngoscope; 2017 Dec; 127(12):E437-E442. PubMed ID: 28561532
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of circulating biomarker score in advanced-stage head and neck squamous cell carcinoma.
Park MJ; Roh JL; Kim SB; Choi SH; Nam SY; Kim SY
Eur J Cancer; 2018 Mar; 92():69-76. PubMed ID: 29428866
[TBL] [Abstract][Full Text] [Related]
16. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial.
Fakhry C; Westra WH; Li S; Cmelak A; Ridge JA; Pinto H; Forastiere A; Gillison ML
J Natl Cancer Inst; 2008 Feb; 100(4):261-9. PubMed ID: 18270337
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of altered blood and tissue glutathione levels in head and neck squamous cell carcinoma cases.
Khan SU; Mahjabeen I; Malik FA; Kayani MA
Asian Pac J Cancer Prev; 2014; 15(18):7603-9. PubMed ID: 25292035
[TBL] [Abstract][Full Text] [Related]
18. Neutrophil-to-lymphocyte ratio: Prognostic indicator for head and neck squamous cell carcinoma.
Rosculet N; Zhou XC; Ha P; Tang M; Levine MA; Neuner G; Califano J
Head Neck; 2017 Apr; 39(4):662-667. PubMed ID: 28075517
[TBL] [Abstract][Full Text] [Related]
19. Lower circulating platelet counts and antiplatelet therapy independently predict better outcomes in patients with head and neck squamous cell carcinoma.
Rachidi S; Wallace K; Day TA; Alberg AJ; Li Z
J Hematol Oncol; 2014 Sep; 7():65. PubMed ID: 25260646
[TBL] [Abstract][Full Text] [Related]
20. NDN and CD1A are novel prognostic methylation markers in patients with head and neck squamous carcinomas.
Virani S; Bellile E; Bradford CR; Carey TE; Chepeha DB; Colacino JA; Helman JI; McHugh JB; Peterson LA; Sartor MA; Taylor JM; Walline HM; Wolf GT; Rozek LS
BMC Cancer; 2015 Oct; 15():825. PubMed ID: 26518708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
